Description
Cross-Site Request Forgery (CSRF) vulnerability in Latepoint LatePoint allows Cross Site Request Forgery.This issue affects LatePoint: from n/a through 4.9.91.
Published: 2024-10-21
Score: 6.5 Medium
EPSS: < 1% Very Low
KEV: No
Impact: n/a
Action: n/a
AI Analysis

Analysis and contextual insights are available on OpenCVE Cloud.

Remediation

No vendor fix or workaround currently provided.

Additional remediation guidance may be available on OpenCVE Cloud.

Tracking

Sign in to view the affected projects.

Advisories
Source ID Title
EUVD EUVD EUVD-2024-40594 Cross-Site Request Forgery (CSRF) vulnerability in Latepoint LatePoint allows Cross Site Request Forgery.This issue affects LatePoint: from n/a through 4.9.91.
History

Thu, 24 Oct 2024 14:15:00 +0000

Type Values Removed Values Added
First Time appeared Latepoint
Latepoint latepoint
CPEs cpe:2.3:a:latepoint:latepoint:*:*:*:*:*:wordpress:*:*
Vendors & Products Latepoint
Latepoint latepoint

Mon, 21 Oct 2024 12:15:00 +0000

Type Values Removed Values Added
Metrics ssvc

{'options': {'Automatable': 'no', 'Exploitation': 'none', 'Technical Impact': 'partial'}, 'version': '2.0.3'}


Mon, 21 Oct 2024 11:15:00 +0000

Type Values Removed Values Added
Description Cross-Site Request Forgery (CSRF) vulnerability in Latepoint LatePoint allows Cross Site Request Forgery.This issue affects LatePoint: from n/a through 4.9.91.
Title WordPress LatePoint plugin <= 4.9.91 - Cross Site Request Forgery (CSRF) vulnerability
Weaknesses CWE-352
References
Metrics cvssV3_1

{'score': 6.5, 'vector': 'CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:H/A:N'}


Subscriptions

Latepoint Latepoint
cve-icon MITRE

Status: PUBLISHED

Assigner: Patchstack

Published:

Updated: 2026-04-28T16:10:14.170Z

Reserved: 2024-08-18T21:56:39.241Z

Link: CVE-2024-43945

cve-icon Vulnrichment

Updated: 2024-10-21T11:39:04.734Z

cve-icon NVD

Status : Analyzed

Published: 2024-10-21T11:15:02.933

Modified: 2024-10-24T13:45:42.487

Link: CVE-2024-43945

cve-icon Redhat

No data.

cve-icon OpenCVE Enrichment

No data.

Weaknesses